IONS - Ionis succeeds in Phase 3 trial for rare disease drug
2023-09-26 07:26:54 ET
More on Ionis
- Seeking Alpha’s Quant Rating on Ionis Pharmaceuticals
- Financial information for Ionis Pharmaceuticals
- Ionis Pharmaceuticals: Mid-Sized Pharma Is A Strong Buy Opportunity For All-Comers
- Novartis and Ionis in pact for new cardiovascular therapy
- AstraZeneca-Ionis deal for eplontersen expands to Latin America
For further details see:
Ionis succeeds in Phase 3 trial for rare disease drug